3[2]George M. Eliopoulos,Robert C. Moellering. Azlocillin,Mezlocillin, and Piperacillin: new broad-spectrum penicillins.Annals of Intenal Medicine. 1982,97 : 755-760. 被引量：1
4[7]Laura J V. Piddock,YU Fang Jin, HL. Turner. Activity of 13 β- lactam agents combined WithBRL42715againstp- lactamaseproducingGram- negativebacteriacomparedto combinations with clavulanic acid, tazobactam and sulbatam. J Antimicro Chemother. 1993,31: 89- 103. 被引量：1
5[8]Wildfeuer-A,Schmalreck- A,Rader-K,et al. Studies on the synergism of sulbactam and - lactam antibiotics underin Vitro conditions andin healthy volunteers after intravenous administration. Drug Res. 1989,39(1):94-100. 被引量：1
6[9]Schmalreck AF, Wildfeuer A. In vitro activity against Clinically important gram - positve andgram - negativebacteria of Sulbactam, alone andincombination With ampicillin, cefotaxime, mezlocillin, andpiperacillin. Arzneimittelforschung.1990,40(10) : 1145 - 1155. 被引量：1
7[10]Manncke K, Springsklee M, Heizmann WR, et al. SUlbactam incombinationwithmezlocillin, piperacillin Orcefotaxime.Clinical and hacteriological resultS in the treatment of severe bacterial ifections. Med - Klin, 1991,15; 86 (9): 454- 460. 被引量：1
8[11]Bauemfeind- A, Grimm- H, Klietmann-W, et al. The effect of SUlbactam on the in Vitroactivity Of mezlocillin,piperacillin,and cefotaxime. Arzneimittelforschung. 1991; 41(8) :831 - 831. 被引量：1
10[16]RobdeB, Wemer u, Hickstein H,et al. Pharmacokinetics of mezlocillin and sulbactam under continuous veno- venous hemodialysis(CVVHI))in intensive care patients with acute renal failure J Clin Pharmacol, 1997,53:111-115. 被引量：1
